Modulation of the fecal bile acid profile by gut microbiota in cirrhosis

Journal of Hepatology

Volumn 58, Issue 5, 2013, Pages 949-955

  Kakiyama, Genta ^a   Pandak, William M ^a   Gillevet, Patrick M ^b   Hylemon, Phillip B ^a   Heuman, Douglas M ^a   Daita, Kalyani ^a   Takei, Hajime ^c   Muto, Akina ^c   Nittono, Hiroshi ^c   Ridlon, Jason M ^a   White, Melanie B ^a   Noble, Nicole A ^a   Monteith, Pamela ^a   Fuchs, Michael ^a   Thacker, Leroy R ^a   Sikaroodi, Masoumeh ^b   Bajaj, Jasmohan S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

^c Junshin Clinic Bile Acid Institute   (Japan)

Author keywords

Bile acid dehydroxylation; Complications of cirrhosis; Dysbiosis; Gut microbiota; Pathogenesis; Rifaximin

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHOLIC ACID; DEOXYCHOLIC ACID; LITHOCHOLIC ACID; RIFAXIMIN;

ADULT; ARTICLE; BACTERIUM; BLAUTIA; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; ENTEROBACTERIACEAE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROXYLATION; INTESTINE FLORA; LACHONOSPIRACEAE; LIQUID CHROMATOGRAPHY; LIVER CIRRHOSIS; MALE; MASS SPECTROMETRY; MICROBIOME; PRIORITY JOURNAL; PYROSEQUENCING; RUMINOCOCCACEAE;

ANTI-INFECTIVE AGENTS; BILE ACIDS AND SALTS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENTEROBACTERIACEAE; FECES; FEMALE; HUMANS; INTESTINES; LIVER CIRRHOSIS; MALE; MICROBIOTA; MIDDLE AGED; PROSPECTIVE STUDIES; RIFAMYCINS; RUMINOCOCCUS; VEILLONELLACEAE;

EID: 84876294967     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.01.003     Document Type: Article

References (27)

1. J.S. Bajaj, J.M. Ridlon, P.B. Hylemon, L.R. Thacker, D.M. Heuman, and S. Smith Linkage of gut microbiome with cognition in hepatic encephalopathy Am J Physiol Gastrointest Liver Physiol 302 2012 G168 175
2. J.S. Bajaj, P.B. Hylemon, J.M. Ridlon, D.M. Heuman, K. Daita, and M.B. White Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation Am J Physiol Gastrointest Liver Physiol 303 2012 G675 685
3. Y. Chen, F. Yang, H. Lu, B. Wang, D. Lei, and Y. Wang Characterization of fecal microbial communities in patients with liver cirrhosis Hepatology 54 2011 562 572
4. K.B. Islam, S. Fukiya, M. Hagio, N. Fujii, S. Ishizuka, and T. Ooka Bile acid is a host factor that regulates the composition of the cecal microbiota in rats Gastroenterology 141 2011 1773 1781
5. J.M. Ridlon, D.J. Kang, and P.B. Hylemon Bile salt biotransformations by human intestinal bacteria J Lipid Res 47 2006 241 259
6. Z.R. Vlahcevic, I. Buhac, C.C. Bell Jr., and L. Swell Abnormal metabolism of secondary bile acids in patients with cirrhosis Gut 11 1970 420 422
7. J.R. Swann, E.J. Want, F.M. Geier, K. Spagou, I.D. Wilson, and J.E. Sidaway Systemic gut microbial modulation of bile acid metabolism in host tissue compartments Proc Natl Acad Sci U S A 108 2011 4523 4530
8. H.M. Hamer, V. De Preter, K. Windey, and K. Verbeke Functional analysis of colonic bacterial metabolism: relevant to health? Am J Physiol Gastrointest Liver Physiol 302 2011 G1 9
9. A. Muto, H. Takei, A. Unno, T. Murai, T. Kurosawa, and S. Ogawa Detection of Delta4-3-oxo-steroid 5beta-reductase deficiency by LC-ESI-MS/MS measurement of urinary bile acids J Chromatogr B Analyt Technol Biomed Life Sci 900 2012 24 31
10. P. Gillevet, M. Sikaroodi, A. Keshavarzian, and E.A. Mutlu Quantitative assessment of the human gut microbiome using multitag pyrosequencing Chem Biodivers 7 2010 1065 1075
11. S. Devkota, Y. Wang, M.W. Musch, V. Leone, H. Fehlner-Peach, and A. Nadimpalli Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice Nature 487 2012 104 108
12. L. Maillette de Buy Wenniger, and U. Beuers Bile salts and cholestasis Dig Liver Dis 42 2010 409 418
13. W.C. McCormick 3rd, C.C. Bell Jr, L. Swell, and Z.R. Vlahcevic Cholic acid synthesis as an index of the severity of liver disease in man Gut 14 1973 895 902
14. Q. Liu, Z.P. Duan, D.K. Ha, S. Bengmark, J. Kurtovic, and S.M. Riordan Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis Hepatology 39 2004 1441 1449
15. H. Duboc, D. Rainteau, S. Rajca, L. Humbert, D. Farabos, and M. Maubert Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome Neurogastroenterol Motil 24 2012 513 520 e246-517
16. J.S. Bajaj, P.M. Gillevet, N.R. Patel, V. Ahluwalia, J.M. Ridlon, and B. Kettenmann A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy Metab Brain Dis 27 2012 205 215
17. O. Riggio, G. Mannaioni, L. Ridola, S. Angeloni, M. Merli, and V. Carla Peripheral and splanchnic indole and oxindole levels in cirrhotic patients: a study on the pathophysiology of hepatic encephalopathy Am J Gastroenterol 105 2010 1374 1381
18. N.M. Bass, K.D. Mullen, A. Sanyal, F. Poordad, G. Neff, and C.B. Leevy Rifaximin treatment in hepatic encephalopathy N Engl J Med 362 2010 1071 1081
19. J. Flores, H.L. Dupont, Z.D. Jiang, P.C. Okhuysen, J.H. Melendez-Romero, and A. Gonzalez-Estrada A randomized, double-blind, pilot study of rifaximin 550 mg versus placebo in the prevention of travelers' diarrhea in Mexico during the dry season J Travel Med 18 2011 333 336
20. E.L. Brown, Q. Xue, Z.D. Jiang, Y. Xu, and H.L. Dupont Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles Antimicrob Agents Chemother 54 2009 388 396
21. C. Darkoh, L.M. Lichtenberger, N. Ajami, E.J. Dial, Z.D. Jiang, and H.L. DuPont Bile acids improve the antimicrobial effect of rifaximin Antimicrob Agents Chemother 54 2010 3618 3624
22. Z.D. Jiang, S. Ke, and H.L. Dupont Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei Int J Antimicrob Agents 35 2010 278 281
23. H. Duboc, D. Rainteau, S. Rajca, L. Humbert, D. Farabos, and M. Maubert Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome Neurogastroenterol Motil 24 2012 e247 513
24. P. Kurdi, K. Kawanishi, K. Mizutani, and A. Yokota Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria J Bacteriol 188 2006 1979 1986
25. P. Tandon, and G. Garcia-Tsao Bacterial infections, sepsis, and multiorgan failure in cirrhosis Semin Liver Dis 28 2008 26 42
26. Z. Teltschik, R. Wiest, J. Beisner, S. Nuding, C. Hofmann, and J. Schoelmerich Intestinal bacterial translocation in cirrhotic rats is related to compromised paneth cell antimicrobial host defence Hepatology 55 4 2011 1154 1163
27. E. Scarpellini, V. Valenza, M. Gabrielli, E.C. Lauritano, G. Perotti, and G. Merra Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? Am J Gastroenterol 105 2010 323 327